$349.91
Value $318B
UNH and VEEV stock compared: price, dividend, valuation and results, from SEC filings.
$349.91
Value $318B
$277.20
Value $45.3B
UnitedHealth (UNH) has a market value of $318B and Veeva Systems (VEEV) $45.3B. Over the last year, with dividends, UNH moved +12.1% and VEEV +0.1%. The P/E is 20.0 for UNH and 44.6 for VEEV. Dividend yield: UNH 2.59%, VEEV none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
UNH$318B
VEEV$45.3B
UNH is 7.0 times VEEV
Revenue, 12 months
UNH$450B
VEEV$3.5B
UNH is 130 times VEEV
Net income, 12 months
UNH$15.9B
VEEV$1.0B
UNH is 16 times VEEV
Operating margin
UNH5.3%
VEEV29.9%
24.6 points apart
ROIC
UNH11.3%
VEEV11.1%
0.2 points apart
P/E
UNH20.0
VEEV44.6
VEEV is 2.2 times UNH
Dividend yield
UNH2.6%
VEEV0.0%
2.6 points apart
5-year return
UNH-14.7%
VEEV-12.0%
2.7 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
UNH-14.7%
VEEV-12.0%
| Period | UNHWith dividends | VEEVWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | +12.1%Price +9.2% | +0.1%Price +0.1% |
| 3 years since November 17, 2023 | -30.5%-11.4% a yearPrice -34.8% | +57.0%+16.2% a yearPrice +57.0% |
| 5 years since November 17, 2021 | -14.7%-3.1% a yearPrice -22.1% | -12.0%-2.5% a yearPrice -12.0% |
| 10 years since November 21, 2016 | +174.7%+10.6% a yearPrice +132.6% | +563.6%+20.8% a yearPrice +563.6% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
UNHUnitedHealthVEEVVeeva Systems
| Price | $349.91 | $277.20 |
|---|---|---|
| Market value | $318B | $45.3B |
| Enterprise value (EV) | $363B | $38.0B |
| P/E | 20.0 | 44.6 |
| P/E, 5-year median | 25.0 | 56.9 |
| P/B | 3.1 | 6.1 |
| EV/EBIT | 15.2 | 36.8 |
| Free cash flow yield | 7.2% | 3.7% |
| Revenue, 12 months | $450B | $3.5B |
|---|---|---|
| Net income, 12 months | $15.9B | $1.0B |
| Free cash flow, 12 months | $22.8B | $1.7B |
| Earnings per share, 12 months | $17.52 | $6.11 |
| Revenue growth, year on year | 11.8% | 16.3% |
| Revenue growth a year, past | +11.7%over 5 years | +16.9%over 5 years |
| EPS growth a year, past | -3.8%over 5 years | +18.2%over 5 years |
| Gross margin | 88.3% | 75.0% |
|---|---|---|
| Operating margin | 5.3% | 29.9% |
| Net margin | 3.5% | 29.3% |
| ROIC | 11.3% | 11.1% |
| ROE | 15.5% | 14.2% |
| Cash | $28.5B | $7.2B |
|---|---|---|
| Total debt | $74.3B | $152M |
| Net debt / EBITDA | 1.6 | – |
| Interest cover | 6.2× | – |
| Dividend yield | 2.6% | – |
|---|---|---|
| Dividend per share, 12 months | $9.06 | – |
| Dividend growth a year, past | +12.6%over 5 years | – |
| Buyback yield | 1.8% | 0.4% |
| Shareholder yield | 4.3% | 0.4% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, UnitedHealth ($318B) is about 7.0 times Veeva Systems ($45.3B), at today's prices.
Since November 21, 2016, UNH's price moved +132.6% and VEEV's +563.6%. With dividends: UNH +174.7% (+10.6% a year), VEEV +563.6% (+20.8% a year). Past returns do not predict future ones.
The dividend yield at today's price is 2.59% for UnitedHealth and none for Veeva Systems. Over the last twelve months they paid $9.06 and – per share.
At today's price, the P/E is 20.0 for UNH and 44.6 for VEEV. The median of the last five years was 25.0 and 56.9, which shows where each stands against its own past.
Over the last twelve months, the net margin was 3.5% for UnitedHealth and 29.3% for Veeva Systems, and the operating margin 5.3% and 29.9%. Revenue was $450B and $3.5B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.